GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » Other Long Term Assets

Takeda Pharmaceutical Co (MEX:TAK N) Other Long Term Assets : MXN60,531 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Other Long Term Assets?

Takeda Pharmaceutical Co's other long-term assets for the quarter that ended in Mar. 2025 was MXN60,531 Mil.

Takeda Pharmaceutical Co's quarterly other long-term assets increased from Sep. 2024 (MXN58,308 Mil) to Dec. 2024 (MXN61,073 Mil) but then stayed the same from Dec. 2024 (MXN61,073 Mil) to Mar. 2025 (MXN60,531 Mil).

Takeda Pharmaceutical Co's annual other long-term assets declined from Mar. 2023 (MXN57,896 Mil) to Mar. 2024 (MXN49,304 Mil) but then increased from Mar. 2024 (MXN49,304 Mil) to Mar. 2025 (MXN60,531 Mil).

Takeda Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Takeda Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Other Long Term Assets Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85,395.95 74,747.48 57,896.07 49,303.70 60,531.09

Takeda Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49,303.70 56,602.57 58,307.69 61,073.05 60,531.09

Takeda Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Takeda Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » Other Long Term Assets
Comparable Companies
TSE:4507 TSE:4523 TSE:4506 TSE:4530 TSE:4540 TSE:4887 TSE:4516 TSE:4551 TSE:4547 TSE:4521 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506
Traded in Other Exchanges
TAK:USA TKPHF:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TAKP34:Brazil TKD:Austria
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Website
https://www.takeda.com
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines